CRONUS PHARMA LLC, — Cephalexin Importer Profile
Pharmaceutical Importer · #11 buyer for Cephalexin · $1.2M import value · 31 shipments · UNITED STATES · DGFT Verified
CRONUS PHARMA LLC, is the #11 importer of Cephalexin from India with $1.2M in import value and 31 verified shipments. CRONUS PHARMA LLC, holds a 0.4% market share in Cephalexin imports based in UNITED STATES. The company sources from 1 verified supplier across 18 formulations shipped to 1 country. Overall, CRONUS PHARMA LLC, imports 2 pharmaceutical products worth $5.5M across 2 therapeutic categories.
CRONUS PHARMA LLC, — Cephalexin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Cephalexin to CRONUS PHARMA LLC,?
Verified from 31 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| AUROBINDO PHARMA LIMITED | $1.2M | 31 | 100.0% |
CRONUS PHARMA LLC, sources Cephalexin from 1 verified Indian supplier based on 31 customs records. The primary supplier is AUROBINDO PHARMA LIMITED accounting for 100.0% of imports.
How Does CRONUS PHARMA LLC, Compare to Nearest Cephalexin Importers?
Buyers ranked immediately above and below #11 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 13 | MORAF PHARMACEUTICALS LIMITED | TANZANIA | $1.7M | 40 | $42.5K |
| 10 | M S SUN PHARMA ANZ PTY LIMITED | AUSTRALIA | $1.6M | 33 | $50.0K |
| 11 | CRONUS PHARMA LLC, ★ | UNITED STATES | $1.6M | 31 | $50.0K |
| 12 | CRONUS PHARMA LLC ★ | UNITED STATES | $1.4M | 29 | $50.0K |
| 17 | SIVEM PHARMACEUTICALS | UNITED STATES | $1.3M | 28 | $47.8K |
CRONUS PHARMA LLC, ranks #11 among 516 Cephalexin importers from India. Average shipment value of $50.0K compared to the market average of $86.7K. The closest competitors by value are MORAF PHARMACEUTICALS LIMITED and M S SUN PHARMA ANZ PTY LIMITED.
Where Does CRONUS PHARMA LLC, Import Cephalexin To?
Destination countries from 31 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.2M | 31 | 100.0% |
CRONUS PHARMA LLC, imports Cephalexin to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $1.2M.
What Cephalexin Formulations Does CRONUS PHARMA LLC, Import?
| Formulation | Value | Shipments |
|---|---|---|
| CEPHALEXIN CAPSULES 500MG (CEPHALEXIN CAPSULES USP 500 MG) (6941 X 500'S PACKS =3470500 NOS)NOS | $150.0K | 3 |
| CEPHALEXIN CAPSULES 500MG (CEPHALEXIN CAPSULES USP 500 MG) (6956 X 500'S PACKS =3478000 NOS)NOS | $150.0K | 3 |
| CEPHALEXIN CAPSULES USP 500MG (5814 X 500'S PACK) | $140.5K | 3 |
| CEPHALEXIN CAPSULES 500MG | $100.0K | 2 |
| CEPHALEXIN CAPSULES 250MG (CEPHALEXIN CAPSULES USP 250 MG) (4649 X 500'S PACKS =2324500 NOS)NOS | $67.8K | 3 |
| CEPHALEXIN CAPSULES 500MG (CEPHALEXIN CAPSULES USP 500 MG) (2313 X 500'S PACKS =1156500 NOS)NOS | $63.1K | 3 |
| CEPHALEXIN CAPSULES USP 250 MG (500'S) ( | $50.0K | 1 |
| CEPHALEXIN CAPSULES USP 500 MG (500'S) ( | $50.0K | 1 |
| CEPHALEXIN CAPSULES 500MG (CEPHALEXIN CAPSULES USP 500 MG) 500'S (4651X500'S PACKS=2325500 NOS ) | $50.0K | 1 |
| CEPHALEXIN CAPSULES 500MG(CEPHALEXIN CAPSULES USP 500 MG)(QTY:3060 PAK 1530000 EACH) | $50.0K | 1 |
CRONUS PHARMA LLC, imports 18 distinct Cephalexin formulations from India. The top formulation is CEPHALEXIN CAPSULES 500MG (CEPHALEXIN CAPSULES USP 500 MG) ( with 3 shipments worth $150.0K.
Regulatory Requirements: Importing Cephalexin into United States
What CRONUS PHARMA LLC, and other importers must comply with to import Cephalexin from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Cephalexin
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Cephalexin from India and How Much Does CRONUS PHARMA LLC, Import?
India exported $44.7M worth of Cephalexin through 5,117 shipments from 223 suppliers to 104 countries, serving 516 buyers globally. CRONUS PHARMA LLC, imports $1.2M of this total, accounting for 0.4% of India's Cephalexin exports with 31 shipments from UNITED STATES. This is verified from 31 customs shipment records covering 18 distinct formulations.
What Is the Average Order Value for CRONUS PHARMA LLC,'s Cephalexin Imports?
CRONUS PHARMA LLC,'s average Cephalexin order value is $37.9K per consignment, based on 31 shipments totaling $1.2M. CRONUS PHARMA LLC, is based in UNITED STATES and ranks #11 among all Cephalexin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Cephalexin to CRONUS PHARMA LLC,?
CRONUS PHARMA LLC, sources Cephalexin from 1 verified Indian supplier: AUROBINDO PHARMA LIMITED ($1.2M, 100.0%). This is based on 31 customs records.
How Does CRONUS PHARMA LLC, Compare to Other Cephalexin Importers?
CRONUS PHARMA LLC, ranks #11 among 516 Cephalexin importers from India with a 0.4% market share. The top 3 importers are ASCEND LABORATORIES,LLC ($13.3M), ASCEND LABORATORIES LLC ($9.5M), BREATHEFREE LANKA PVT LTD ($6.8M). CRONUS PHARMA LLC, processed 31 shipments from UNITED STATES.
About CRONUS PHARMA LLC,
CRONUS PHARMA LLC, imports 2 products worth $5.5M. Beyond Cephalexin, top products include Cefpodoxime. View the complete CRONUS PHARMA LLC, profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cephalexin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cephalexin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: CRONUS PHARMA LLC, matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as CRONUS PHARMA LLC,'s capped import value divided by total capped export value for Cephalexin across all Indian exporters.
- 5.Verified Records: This page is backed by 31 individual customs records matching CRONUS PHARMA LLC, importing Cephalexin, covering 18 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 104+ countries, 516+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cephalexin Import Data for CRONUS PHARMA LLC,
Access order-level details, pricing data, supplier connections, and competitive analysis for CRONUS PHARMA LLC,'s Cephalexin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
CRONUS PHARMA LLC,
Full Company Profile →
2 products · $5.5M total trade · 2 categories
CRONUS PHARMA LLC, × Cephalexin
Verified from customs records
Company Overview
Top Products by CRONUS PHARMA LLC,
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for CRONUS PHARMA LLC,.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cephalexin. For current order-level data, contact TransData Nexus.